AI Science Tracker

Johnson & Johnson

1 discovery from 2025

Discoveries

Machine learning finds plasma protein signals up to 14 years before Parkinson diagnosis

Using UK Biobank measurements of 2,937 plasma proteins, researchers found 446 dysregulated proteins in incident Parkinson cases and used machine learning to select a 23-protein panel for prediction. The panel achieved test AUCs of 0.78 in incident and 0.795 in prevalent cases; nine selected proteins were already dysregulated 10–14 years before diagnosis. In a separate Parkinson’s Progression Markers Initiative cohort, a 16-protein subset shared between platforms achieved validation AUC up to 0.76.

Technology: Support vector machine and other machine-learning models, with recursive feature elimination for panel selection

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Using UK Biobank measurements of 2,937 plasma proteins, researchers found 446 dysregulated proteins in incident Parkinson cases and used machine learning to select a 23-protein panel for prediction.
  • Still unknown: The result is a retrospective biomarker/prediction study, not a validated screening test or evidence that intervention based on the panel improves outcomes. The external PPMI analysis retrained and tested models in that cohort rather than evaluating a frozen UK Biobank model; validation AUCs varied by visit definition, and the reported maximum was 0.76. Protein associations and co-expression modules do not establish causal mechanisms. It is distinct from the earlier 2024 iRBD study in this ledger (DOI 10.1038/s41467-024-48961-3): separate cohorts and a different 23-protein/14-year result versus an eight-protein targeted panel and up-to-seven-year conversion finding; this record does not claim first discovery of presymptomatic plasma signals in Parkinson disease.
  • AI role: Machine-learning classifiers were trained on UK Biobank plasma proteomic measurements to predict incident Parkinson disease; recursive feature elimination selected a 23-protein subset. The authors then tested the shared protein subset in the separate PPMI cohort using its own train/test split.

Evidence sources: https://academic.oup.com/brain/article/149/4/1254/8234010

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 6 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.